Does AMRUBICIN Cause Interstitial lung disease? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Interstitial lung disease have been filed in association with AMRUBICIN. This represents 10.8% of all adverse event reports for AMRUBICIN.
17
Reports of Interstitial lung disease with AMRUBICIN
10.8%
of all AMRUBICIN reports
2
Deaths
3
Hospitalizations
How Dangerous Is Interstitial lung disease From AMRUBICIN?
Of the 17 reports, 2 (11.8%) resulted in death, 3 (17.6%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMRUBICIN. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does AMRUBICIN Cause?
Disease recurrence (30)
Neutropenia (22)
Drug ineffective (21)
Febrile neutropenia (16)
Leukopenia (15)
Anaemia (14)
Acute myeloid leukaemia (13)
Disease progression (12)
Thrombocytopenia (12)
Small cell lung cancer (10)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which AMRUBICIN Alternatives Have Lower Interstitial lung disease Risk?
AMRUBICIN vs AMSACRINE
AMRUBICIN vs ANAGRELIDE
AMRUBICIN vs ANAKINRA
AMRUBICIN vs ANAMORELIN
AMRUBICIN vs ANASTROZOLE